Key result
Combining myoglobin with standard cardiac troponins may optimize early and definitive MI diagnosis.
Why the study?
What is the clinical significance and effectiveness of various serum biomarkers in the diagnosis of myocardial infarction?
Population
Patients with suspected acute myocardial infarction
Design
Review
Authors
Loading...
Troponins remain MI diagnostic standard; dual myoglobin approach leaves open need for prospective validation.
What is the clinical significance and effectiveness of various serum biomarkers in the diagnosis of myocardial infarction?
This review highlights the ongoing evolution of MI biomarkers, emphasizing the gold standard role of troponins and the potential utility of early markers like myoglobin and emerging novel biomarkers.
Kaur et al. (2013) conducted a review in Myocardial infarction. Serum biomarkers was evaluated. Cardiac troponins remain the gold standard for diagnosing myocardial infarction, though a dual-biomarker approach using myoglobin and troponins is proposed for optimal early and definitive diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: